메뉴 건너뛰기




Volumn 17, Issue 1, 2016, Pages

Targeted radionuclide therapy of human tumors

Author keywords

Antibody; Auger electron; Peptide; Radio immunotherapy; Radionuclide; Targeted therapy; emitter; emitter

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ACTINIUM 225; BISMUTH 212; BISMUTH 213; CLIVATUZUMAB TETRAXETAN Y 90; COPPER 64; COPPER 67; DRUG CARRIER; EPRATUZUMAB; IBRITUMOMAB TIUXETAN; IODINE 131; LABETUZUMAB Y 90; LEAD 212; LUTETIUM 177; MONOCLONAL ANTIBODY LYM 1; PEMTUMOMAB; RADIOISOTOPE; RADIUM CHLORIDE RA 223; REACTIVE OXYGEN METABOLITE; RHENIUM 188; SAMARIUM 153; SOMATOSTATIN; STRONTIUM 89; TOSITUMOMAB I 131; YTTRIUM 90; ZIRCONIUM 89;

EID: 84952668233     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17010033     Document Type: Review
Times cited : (153)

References (99)
  • 2
    • 0019981777 scopus 로고
    • Radioimmunodiagnosis and radioimmunotherapy
    • PubMed
    • Sfakianakis, G.N.; DeLand, F.H. Radioimmunodiagnosis and radioimmunotherapy, 1982. J. Nucl. Med. 1982, 23, 840–850. [PubMed]
    • (1982) J. Nucl. Med , vol.1982 , Issue.23 , pp. 840-850
    • Sfakianakis, G.N.1    Deland, F.H.2
  • 3
    • 0025801780 scopus 로고
    • Radioimmunotherapy of malignancies
    • PubMed
    • Reilly, R.M. Radioimmunotherapy of malignancies. Clin. Pharm. 1991, 10, 359–375. [PubMed]
    • (1991) Clin. Pharm , vol.10 , pp. 359-375
    • Reilly, R.M.1
  • 5
    • 85061995607 scopus 로고    scopus 로고
    • Navarro-Teulon, I. Introduction to radiobiology of targeted radionuclide therapy
    • [CrossRef][PubMed]
    • Pouget, J.P.; Lozza, C.; Deshayes, E.; Boudousq, V.; Navarro-Teulon, I. Introduction to radiobiology of targeted radionuclide therapy. Front. Med. 2015, 2. [CrossRef][PubMed]
    • (2015) Front. Med
    • Pouget, J.P.1    Lozza, C.2    Deshayes, E.3    Boudousq, V.4
  • 6
    • 84919464054 scopus 로고    scopus 로고
    • Radiotherapy and immunogenic cell death
    • [CrossRef][PubMed]
    • Golden, E.B.; Apetoh, L. Radiotherapy and immunogenic cell death. Semin. Radiat. Oncol. 2015, 25, 11–17. [CrossRef][PubMed]
    • (2015) Semin. Radiat. Oncol , vol.25 , pp. 11-17
    • Golden, E.B.1    Apetoh, L.2
  • 7
    • 0024195429 scopus 로고
    • DNA damage produced by ionizing radiation in mammalian cells: Identities, mechanisms of formation, and reparability
    • [PubMed]
    • Ward, J.F. DNA damage produced by ionizing radiation in mammalian cells: Identities, mechanisms of formation, and reparability. Prog. Nucleic Acid Res. Mol. Biol. 1988, 35, 95–125. [PubMed]
    • (1988) Prog. Nucleic Acid Res. Mol. Biol , vol.35 , pp. 95-125
    • Ward, J.F.1
  • 8
    • 84883300098 scopus 로고    scopus 로고
    • Advances in anticancer radiopharmaceuticals
    • [CrossRef][PubMed]
    • Jackson, M.R.; Falzone, N.; Vallis, K.A. Advances in anticancer radiopharmaceuticals. Clin. Oncol. 2013, 25, 604–609. [CrossRef][PubMed]
    • (2013) Clin. Oncol , vol.25 , pp. 604-609
    • Jackson, M.R.1    Falzone, N.2    Vallis, K.A.3
  • 9
    • 14844359242 scopus 로고    scopus 로고
    • Radiobiologic principles in radionuclide therapy
    • PubMed
    • Kassis, A.I.; Adelstein, S.J. Radiobiologic principles in radionuclide therapy. J. Nucl. Med. 2005, 46, 4S–12S. [PubMed]
    • (2005) J. Nucl. Med , vol.46
    • Kassis, A.I.1    Adelstein, S.J.2
  • 10
    • 84961060184 scopus 로고
    • Effects of different radiations on human cells in tissue culture. Ii. Biological experiments
    • [CrossRef][PubMed]
    • Barendsen, G.W.; Beusker, T.L.; Vergroesen, A.J.; Budke, L. Effects of different radiations on human cells in tissue culture. Ii. Biological experiments. Radiat. Res. 1960, 13, 841–849. [CrossRef][PubMed]
    • (1960) Radiat. Res , vol.13 , pp. 841-849
    • Barendsen, G.W.1    Beusker, T.L.2    Vergroesen, A.J.3    Budke, L.4
  • 11
    • 0034975275 scopus 로고    scopus 로고
    • Therapeutic radionuclides and nuclear data
    • CrossRef
    • Qaim, S.M. Therapeutic radionuclides and nuclear data. Radiochim. Acta 2001, 89, 297–302. [CrossRef]
    • (2001) Radiochim. Acta , vol.89 , pp. 297-302
    • Qaim, S.M.1
  • 12
    • 84862682101 scopus 로고    scopus 로고
    • Effective use of strontium-89 in osseous metastases
    • [CrossRef][PubMed]
    • Kuroda, I. Effective use of strontium-89 in osseous metastases. Ann. Nucl. Med. 2012, 26, 197–206. [CrossRef][PubMed]
    • (2012) Ann. Nucl. Med , vol.26 , pp. 197-206
    • Kuroda, I.1
  • 13
    • 0034145611 scopus 로고    scopus 로고
    • The aapm/rsna physics tutorial for residents: Internal radiation dosimetry: Principles and applications
    • [CrossRef][PubMed]
    • Toohey, R.E.; Stabin, M.G.; Watson, E.E. The aapm/rsna physics tutorial for residents: Internal radiation dosimetry: Principles and applications. Radiographics 2000, 20, 533–546. [CrossRef][PubMed]
    • (2000) Radiographics , vol.20 , pp. 533-546
    • Toohey, R.E.1    Stabin, M.G.2    Watson, E.E.3
  • 14
    • 84868191187 scopus 로고    scopus 로고
    • Fractionated radioimmunotherapy with (90) y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
    • CrossRefPubMed
    • Ocean, A.J.; Pennington, K.L.; Guarino, M.J.; Sheikh, A.; Bekaii-Saab, T.; Serafini, A.N.; Lee, D.; Sung, M.W.; Gulec, S.A.; Goldsmith, S.J.; et al. Fractionated radioimmunotherapy with (90) y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial. Cancer 2012, 118, 5497–5506. [CrossRef][PubMed]
    • (2012) Cancer , vol.118 , pp. 5497-5506
    • Ocean, A.J.1    Pennington, K.L.2    Guarino, M.J.3    Sheikh, A.4    Bekaii-Saab, T.5    Serafini, A.N.6    Lee, D.7    Sung, M.W.8    Gulec, S.A.9    Goldsmith, S.J.10
  • 16
    • 79959430516 scopus 로고    scopus 로고
    • Astatine-211: Production and availability
    • CrossRefPubMed
    • Zalutsky, M.R.; Pruszynski, M. Astatine-211: Production and availability. Curr. Radiopharm. 2011, 4, 177–185. [CrossRef][PubMed]
    • (2011) Curr. Radiopharm , vol.4 , pp. 177-185
    • Zalutsky, M.R.1    Pruszynski, M.2
  • 18
    • 84863556127 scopus 로고    scopus 로고
    • Rhenium-188: Availability from the (188)w/(188)re generator and status of current applications
    • CrossRefPubMed
    • Pillai, M.R.; Dash, A.; Knapp, F.F., Rhenium-188: Availability from the (188)w/(188)re generator and status of current applications. Curr. Radiopharm. 2012, 5, 228–243. [CrossRef][PubMed]
    • (2012) Curr. Radiopharm , vol.5 , pp. 228-243
    • Pillai, M.R.1    Dash, A.2    Knapp, F.F.3
  • 21
    • 78349269462 scopus 로고    scopus 로고
    • New antibody conjugates in cancer therapy
    • CrossRefPubMed
    • Govindan, S.V.; Goldenberg, D.M. New antibody conjugates in cancer therapy. Sci. World J. 2010, 10, 2070–2089. [CrossRef][PubMed]
    • (2010) Sci. World J , vol.10 , pp. 2070-2089
    • Govindan, S.V.1    Goldenberg, D.M.2
  • 22
    • 84900389533 scopus 로고    scopus 로고
    • Radioimmunotherapy with alpha-particle-emitting radionuclides
    • CrossRefPubMed
    • Seidl, C. Radioimmunotherapy with alpha-particle-emitting radionuclides. Immunotherapy 2014, 6, 431–458. [CrossRef][PubMed]
    • (2014) Immunotherapy , vol.6 , pp. 431-458
    • Seidl, C.1
  • 23
    • 84908322778 scopus 로고    scopus 로고
    • Radiolabeled apoptosis imaging agents for early detection of response to therapy
    • CrossRef][PubMed
    • Ogawa, K.; Aoki, M. Radiolabeled apoptosis imaging agents for early detection of response to therapy. Sci. World J. 2014, 2014, 732603. [CrossRef][PubMed]
    • Sci. World J , vol.2014 , pp. 2014
    • Ogawa, K.1    Aoki, M.2
  • 24
    • 84929408050 scopus 로고    scopus 로고
    • Radioiodine therapy in differentiated thyroid cancer: The first targeted therapy in oncology
    • CrossRefPubMed
    • Chung, J.K.; Cheon, G.J. Radioiodine therapy in differentiated thyroid cancer: The first targeted therapy in oncology. Endocrinol. Metab. 2014, 29, 233–239. [CrossRef][PubMed]
    • (2014) Endocrinol. Metab. , vol.29 , pp. 233-239
    • Chung, J.K.1    Cheon, G.J.2
  • 25
    • 0025667672 scopus 로고
    • Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid
    • CrossRef
    • Seidlin, S.M.; Marinelli, L.D.; Oshry, E. Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid. J. Am. Med. Assoc. 1990, 40, 299–317. [CrossRef]
    • (1990) J. Am. Med. Assoc , vol.40 , pp. 299-317
    • Seidlin, S.M.1    Marinelli, L.D.2    Oshry, E.3
  • 26
    • 0030053759 scopus 로고    scopus 로고
    • Cloning and characterization of the thyroid iodide transporter
    • [CrossRef][PubMed]
    • Dai, G.; Levy, O.; Carrasco, N. Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379, 458–460. [CrossRef][PubMed]
    • (1996) Nature , vol.379 , pp. 458-460
    • Dai, G.1    Levy, O.2    Carrasco, N.3
  • 27
    • 79955046955 scopus 로고    scopus 로고
    • Feasibility of a novel positive feedback effect of 131i-promoted bac-egr1-hnis expression in malignant glioma through baculovirus
    • [CrossRef][PubMed]
    • Guo, R.; Zhang, R.; Pan, Y.; Xu, H.; Zhang, M.; Liang, S.; Wang, L.; Zhang, Y.; Li, B. Feasibility of a novel positive feedback effect of 131i-promoted bac-egr1-hnis expression in malignant glioma through baculovirus: A comparative study with bac-cmv-hnis. Nucl. Med. Commun. 2011, 32, 402–409. [CrossRef][PubMed]
    • (2011) A Comparative Study with Bac-Cmv-Hnis. Nucl. Med. Commun. , vol.32 , pp. 402-409
    • Guo, R.1    Zhang, R.2    Pan, Y.3    Xu, H.4    Zhang, M.5    Liang, S.6    Wang, L.7    Zhang, Y.8    Li, B.9
  • 28
    • 35348857500 scopus 로고    scopus 로고
    • The importance of sodium/iodide symporter (Nis) for thyroid cancer management
    • CrossRef
    • Carvalho, D.P.; Ferreira, A.C. The importance of sodium/iodide symporter (nis) for thyroid cancer management. Arq. Bras. Endocrinol. Metab. 2007, 51, 672–682. [CrossRef]
    • (2007) Arq. Bras. Endocrinol. Metab , vol.51 , pp. 672-682
    • Carvalho, D.P.1    Ferreira, A.C.2
  • 29
    • 1442348110 scopus 로고    scopus 로고
    • Transcriptional regulation of human sodium/iodide symporter gene: A role for redox factor-1
    • [CrossRef][PubMed]
    • Puppin, C.; Arturi, F.; Ferretti, E.; Russo, D.; Sacco, R.; Tell, G.; Damante, G.; Filetti, S. Transcriptional regulation of human sodium/iodide symporter gene: A role for redox factor-1. Endocrinology 2004, 145, 1290–1293. [CrossRef][PubMed]
    • (2004) Endocrinology , vol.145 , pp. 1290-1293
    • Puppin, C.1    Arturi, F.2    Ferretti, E.3    Russo, D.4    Sacco, R.5    Tell, G.6    Damante, G.7    Filetti, S.8
  • 30
    • 77956115891 scopus 로고    scopus 로고
    • Nf-kappab p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor pax8
    • [CrossRef][PubMed]
    • Nicola, J.P.; Nazar, M.; Mascanfroni, I.D.; Pellizas, C.G.; Masini-Repiso, A.M. Nf-kappab p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor pax8. Mol. Endocrinol. 2010, 24, 1846–1862. [CrossRef][PubMed]
    • (2010) Mol. Endocrinol , vol.24 , pp. 1846-1862
    • Nicola, J.P.1    Nazar, M.2    Mascanfroni, I.D.3    Pellizas, C.G.4    Masini-Repiso, A.M.5
  • 31
    • 79952736015 scopus 로고    scopus 로고
    • Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma
    • [CrossRef][PubMed]
    • Chung, J.-K.; Youn, H.W.; Kang, J.H.; Lee, H.Y.; Kang, K.W. Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma. Nucl. Med. Mol. Imaging 2010, 44, 4–14. [CrossRef][PubMed]
    • (2010) Nucl. Med. Mol. Imaging , vol.44 , pp. 4-14
    • Chung, J.-K.1    Youn, H.W.2    Kang, J.H.3    Lee, H.Y.4    Kang, K.W.5
  • 32
    • 84897939554 scopus 로고    scopus 로고
    • Bone-seeking radiopharmaceuticals for treatment of osseous metastases, part 1: Alpha therapy with 223ra-dichloride
    • [CrossRef][PubMed]
    • Pandit-Taskar, N.; Larson, S.M.; Carrasquillo, J.A. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, part 1: Alpha therapy with 223ra-dichloride. J. Nucl. Med. 2014, 55, 268–274. [CrossRef][PubMed]
    • (2014) J. Nucl. Med , vol.55 , pp. 268-274
    • Pandit-Taskar, N.1    Larson, S.M.2    Carrasquillo, J.A.3
  • 33
    • 84859476468 scopus 로고    scopus 로고
    • The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases
    • PubMed
    • Tomblyn, M. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases. Cancer Control 2012, 19, 137–144. [PubMed]
    • (2012) Cancer Control , vol.19 , pp. 137-144
    • Tomblyn, M.1
  • 35
    • 84952671433 scopus 로고    scopus 로고
    • Systemic targeted alpha radiotherapy for cancer
    • [CrossRef][PubMed]
    • Allen, B. Systemic targeted alpha radiotherapy for cancer. J. Biomed. Phys. Eng. 2013, 3, 67–80. [CrossRef][PubMed]
    • (2013) J. Biomed. Phys. Eng , vol.3 , pp. 67-80
    • Allen, B.1
  • 36
    • 84891472678 scopus 로고    scopus 로고
    • Targeted radionuclide therapy—An overview
    • [CrossRef][PubMed]
    • Dash, A.; Knapp, F.F.; Pillai, M.R. Targeted radionuclide therapy—An overview. Curr. Radiopharm. 2013, 6, 152–180. [CrossRef][PubMed]
    • (2013) Curr. Radiopharm , vol.6 , pp. 152-180
    • Dash, A.1    Knapp, F.F.2    Pillai, M.R.3
  • 37
    • 84858785688 scopus 로고    scopus 로고
    • Antibody therapy of cancer
    • [CrossRef][PubMed]
    • Scott, A.M.; Wolchok, J.D.; Old, L.J. Antibody therapy of cancer. Nat. Rev. Cancer 2012, 12, 278–287. [CrossRef][PubMed]
    • (2012) Nat. Rev. Cancer , vol.12 , pp. 278-287
    • Scott, A.M.1    Wolchok, J.D.2    Old, L.J.3
  • 38
    • 84929885314 scopus 로고    scopus 로고
    • Building better monoclonal antibody-based therapeutics
    • [CrossRef][PubMed]
    • Weiner, G.J. Building better monoclonal antibody-based therapeutics. Nat. Rev. Cancer 2015, 15, 361–370. [CrossRef][PubMed]
    • (2015) . Rev. Cancer , vol.15 , pp. 361-370
    • Weiner, G.1
  • 40
    • 84901944842 scopus 로고    scopus 로고
    • Peptides for diagnosis and treatment of colorectal cancer
    • [CrossRef][PubMed]
    • Shapira, S.; Fokra, A.; Arber, N.; Kraus, S. Peptides for diagnosis and treatment of colorectal cancer. Curr. Med. Chem. 2014, 21, 2410–2416. [CrossRef][PubMed]
    • (2014) Curr. Med. Chem. , vol.21 , pp. 2410-2416
    • Shapira, S.1    Fokra, A.2    Arber, N.3    Kraus, S.4
  • 41
    • 84928898755 scopus 로고    scopus 로고
    • Multifunctional nanoparticles for use in theranostic applications
    • [CrossRef][PubMed]
    • Cole, J.T.; Holland, N.B. Multifunctional nanoparticles for use in theranostic applications. Drug Deliv. Transl. Res. 2015, 5, 295–309. [CrossRef][PubMed]
    • (2015) Drug Deliv. Transl. Res , vol.5 , pp. 295-309
    • Cole, J.T.1    Holland, N.B.2
  • 42
    • 84940956193 scopus 로고    scopus 로고
    • Toward a full understanding of the epr effect in primary and metastatic tumors as well as issues related to its heterogeneity
    • [CrossRef][PubMed]
    • Maeda, H. Toward a full understanding of the epr effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv. Drug Deliv. Rev. 2015, 91, 3–6. [CrossRef][PubMed]
    • (2015) Adv. Drug Deliv. Rev , vol.91 , pp. 3-6
    • Maeda, H.1
  • 43
    • 84907164048 scopus 로고    scopus 로고
    • Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: Samarium-153-edtmp and radium-223
    • PubMed
    • Anderson, P.M.; Subbiah, V.; Rohren, E. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: Samarium-153-edtmp and radium-223. Adv. Exp. Med. Biol. 2014, 804, 291–304. [PubMed]
    • (2014) Adv. Exp. Med. Biol. , vol.804 , pp. 291-304
    • Anderson, P.M.1    Subbiah, V.2    Rohren, E.3
  • 44
    • 35748943826 scopus 로고    scopus 로고
    • Anti-cancer therapies targeting the tumor stroma. Cancer Immunol
    • [CrossRef][PubMed]
    • Hofmeister, V.; Schrama, D.; Becker, J.C. Anti-cancer therapies targeting the tumor stroma. Cancer Immunol. Immunother. 2008, 57, 1–17. [CrossRef][PubMed]
    • (2008) Immunother , vol.57 , pp. 1-17
    • Hofmeister, V.1    Schrama, D.2    Becker, J.C.3
  • 45
    • 84933505636 scopus 로고    scopus 로고
    • Monoclonal antibodies in acute lymphoblastic leukemia
    • [CrossRef][PubMed]
    • Jabbour, E.; O’Brien, S.; Ravandi, F.; Kantarjian, H. Monoclonal antibodies in acute lymphoblastic leukemia. Blood 2015, 125, 4010–4016. [CrossRef][PubMed]
    • (2015) Blood , vol.125 , pp. 4010-4016
    • Jabbour, E.1    O’Brien, S.2    Ravandi, F.3    Kantarjian, H.4
  • 46
    • 84904251878 scopus 로고    scopus 로고
    • Practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia
    • [CrossRef][PubMed]
    • Seifert, R.P.; Bulkeley, W.,; Zhang, L.; Menes, M.; Bui, M.M. A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia. Ann. Diagn. Pathol. 2014, 18, 253–260. [CrossRef][PubMed]
    • (2014) Ann. Diagn. Pathol , vol.18 , pp. 253-260
    • Seifert, R.P.1    Bulkeley, W.2    Zhang, L.3    Menes, M.4    Bui, M.5
  • 47
    • 84952656924 scopus 로고    scopus 로고
    • Biomarkers for immunotherapy in genitourinary malignancies
    • [CrossRef][PubMed]
    • Slovin, S. Biomarkers for immunotherapy in genitourinary malignancies. Urol. Oncol. 2015, 18, 253–260. [CrossRef][PubMed]
    • (2015) Urol. Oncol , vol.18 , pp. 253-260
    • Slovin, S.1
  • 48
    • 68349091432 scopus 로고    scopus 로고
    • Delivering cytokines at tumor site: The immunocytokine-conjugated anti-edb-fibronectin antibody case
    • [CrossRef][PubMed]
    • Ronca, R.; Sozzani, S.; Presta, M.; Alessi, P. Delivering cytokines at tumor site: The immunocytokine-conjugated anti-edb-fibronectin antibody case. Immunobiology 2009, 214, 800–810. [CrossRef][PubMed]
    • (2009) Immunobiology , vol.214 , pp. 800-810
    • Ronca, R.1    Sozzani, S.2    Presta, M.3    Alessi, P.4
  • 49
    • 0029832918 scopus 로고    scopus 로고
    • Organ-specific expression of the colon cancer antigen a33, a cell surface target for antibody-based therapy
    • [CrossRef][PubMed]
    • Garinchesa, P.; Sakamoto, J.; Welt, S.; Real, F.; Rettig, W.; Old, L. Organ-specific expression of the colon cancer antigen a33, a cell surface target for antibody-based therapy. Int. J. Oncol. 1996, 9, 465–471. [CrossRef][PubMed]
    • (1996) Int. J. Oncol , vol.9 , pp. 465-471
    • Garinchesa, P.1    Sakamoto, J.2    Welt, S.3    Real, F.4    Rettig, W.5    Old, L.6
  • 50
    • 84865410155 scopus 로고    scopus 로고
    • Optimizing radioimmunoconjugate delivery in the treatment of solid tumor. Cancer Treat
    • [CrossRef][PubMed]
    • Huang, C.Y.; Pourgholami, M.H.; Allen, B.J. Optimizing radioimmunoconjugate delivery in the treatment of solid tumor. Cancer Treat. Rev. 2012, 38, 854–860. [CrossRef][PubMed]
    • (2012) Rev , vol.38 , pp. 854-860
    • Huang, C.Y.1    Pourgholami, M.H.2    Allen, B.J.3
  • 51
    • 84875965291 scopus 로고    scopus 로고
    • Radioimmunotherapy for hematopoietic cell transplantation
    • [CrossRef][PubMed]
    • Jurcic, J.G. Radioimmunotherapy for hematopoietic cell transplantation. Immunotherapy 2013, 5, 383–394. [CrossRef][PubMed]
    • (2013) Immunotherapy , vol.5 , pp. 383-394
    • Jurcic, J.G.1
  • 52
    • 84936153380 scopus 로고    scopus 로고
    • Cd5- and cd23-positive splenic diffuse large b-cell lymphoma with very low cd20 expression
    • [CrossRef][PubMed]
    • Tabata, R.; Iwama, H.; Tabata, C.; Yasumizu, R.; Kojima, M. Cd5- and cd23-positive splenic diffuse large b-cell lymphoma with very low cd20 expression. J. Clin. Exp. Hematop. 2014, 54, 155–161. [CrossRef][PubMed]
    • (2014) J. Clin. Exp. Hematop , vol.54 , pp. 155-161
    • Tabata, R.1    Iwama, H.2    Tabata, C.3    Yasumizu, R.4    Kojima, M.5
  • 53
    • 0034501637 scopus 로고    scopus 로고
    • Anti-cd30 antibody-based therapy
    • [CrossRef][PubMed]
    • Koon, H.B.; Junghans, R.P. Anti-cd30 antibody-based therapy. Curr. Opin. Oncol. 2000, 12, 588–593. [CrossRef][PubMed]
    • (2000) Curr. Opin. Oncol , vol.12 , pp. 588-593
    • Koon, H.B.1    Junghans, R.P.2
  • 54
    • 33748045787 scopus 로고    scopus 로고
    • The anti-cd25 monoclonal antibody 7g7/b6, armed with the alpha-emitter 211at, provides effective radioimmunotherapy for a murine model of leukemia
    • [CrossRef][PubMed]
    • Zhang, M.; Yao, Z.; Zhang, Z.; Garmestani, K.; Talanov, V.S.; Plascjak, P.S.; Yu, S.; Kim, H.S.; Goldman, C.K.; Paik, C.H.; et al. The anti-cd25 monoclonal antibody 7g7/b6, armed with the alpha-emitter 211at, provides effective radioimmunotherapy for a murine model of leukemia. Cancer Res. 2006, 66, 8227–8232. [CrossRef][PubMed]
    • (2006) Cancer Res , vol.66 , pp. 8227-8232
    • Zhang, M.1    Yao, Z.2    Zhang, Z.3    Garmestani, K.4    Talanov, V.S.5    Plascjak, P.S.6    Yu, S.7    Kim, H.S.8    Goldman, C.K.9    Paik, C.H.10
  • 55
    • 27244458791 scopus 로고    scopus 로고
    • Phase ii trial of carcinoembryonic antigen radioimmunotherapy with 131i-labetuzumab after salvage resection of colorectal metastases in the liver: Five-year safety and efficacy results
    • [CrossRef][PubMed]
    • Liersch, T.; Meller, J.; Kulle, B.; Behr, T.M.; Markus, P.; Langer, C.; Ghadimi, B.M.; Wegener, W.A.; Kovacs, J.; Horak, I.D.; et al. Phase ii trial of carcinoembryonic antigen radioimmunotherapy with 131i-labetuzumab after salvage resection of colorectal metastases in the liver: Five-year safety and efficacy results. J. Clin. Oncol. 2005, 23, 6763–6770. [CrossRef][PubMed]
    • (2005) J. Clin. Oncol. , vol.23 , pp. 6763-6770
    • Liersch, T.1    Meller, J.2    Kulle, B.3    Behr, T.M.4    Markus, P.5    Langer, C.6    Ghadimi, B.M.7    Wegener, W.A.8    Kovacs, J.9    Horak, I.D.10
  • 56
    • 84884536175 scopus 로고    scopus 로고
    • Phase ii study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody j591 for metastatic castration-resistant prostate cancer
    • [CrossRef][PubMed]
    • Tagawa, S.T.; Milowsky, M.I.; Morris, M.; Vallabhajosula, S.; Christos, P.; Akhtar, N.H.; Osborne, J.; Goldsmith, S.J.; Larson, S.; Taskar, N.P.; et al. Phase ii study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody j591 for metastatic castration-resistant prostate cancer. Clin. Cancer Res. 2013, 19, 5182–5191. [CrossRef][PubMed]
    • (2013) Clin. Cancer Res , vol.19 , pp. 5182-5191
    • Tagawa, S.T.1    Milowsky, M.I.2    Morris, M.3    Vallabhajosula, S.4    Christos, P.5    Akhtar, N.H.6    Osborne, J.7    Goldsmith, S.J.8    Larson, S.9    Taskar, N.P.10
  • 58
    • 80053000534 scopus 로고    scopus 로고
    • Analysis of patient survival in a phase I trial of systemic targeted alpha-therapy for metastatic melanoma
    • [CrossRef][PubMed]
    • Allen, B.J.; Singla, A.A.; Rizvi, S.M.; Graham, P.; Bruchertseifer, F.; Apostolidis, C.; Morgenstern, A. Analysis of patient survival in a phase I trial of systemic targeted alpha-therapy for metastatic melanoma. Immunotherapy 2011, 3, 1041–1050. [CrossRef][PubMed]
    • (2011) Immunotherapy , vol.3 , pp. 1041-1050
    • Allen, B.J.1    Singla, A.A.2    Rizvi, S.M.3    Graham, P.4    Bruchertseifer, F.5    Apostolidis, C.6    Morgenstern, A.7
  • 60
    • 32144463528 scopus 로고    scopus 로고
    • Targeted radionuclide therapy with 90y-dotatoc in patients with neuroendocrine tumors
    • PubMed
    • Forrer, F.; Waldherr, C.; Maecke, H.R.; Mueller-Brand, J. Targeted radionuclide therapy with 90y-dotatoc in patients with neuroendocrine tumors. Anticancer Res. 2006, 26, 703–707. [PubMed]
    • (2006) Anticancer Res , vol.26 , pp. 703-707
    • Forrer, F.1    Waldherr, C.2    Maecke, H.R.3    Mueller-Brand, J.4
  • 62
    • 79954439894 scopus 로고    scopus 로고
    • Yttrium-90 dotatoc therapy in gep-net and other sst2 expressing tumors: A selected review
    • [CrossRef][PubMed]
    • Nisa, L.; Savelli, G.; Giubbini, R. Yttrium-90 dotatoc therapy in gep-net and other sst2 expressing tumors: A selected review. Ann. Nucl. Med. 2011, 25, 75–85. [CrossRef][PubMed]
    • (2011) Ann. Nucl. Med , vol.25 , pp. 75-85
    • Nisa, L.1    Savelli, G.2    Giubbini, R.3
  • 66
    • 0029928295 scopus 로고    scopus 로고
    • Normal tissue radiosensitivity–how important is it? Clin
    • CrossRef
    • Burnet, N.G.; Wurm, R.; Nyman, J.; Peacock, J.H. Normal tissue radiosensitivity–how important is it? Clin. Oncol. 1996, 8, 25–34. [CrossRef]
    • (1996) Oncol , vol.8 , pp. 25-34
    • Burnet, N.G.1    Wurm, R.2    Nyman, J.3    Peacock, J.H.4
  • 67
    • 33746707858 scopus 로고    scopus 로고
    • High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223ra: Adjuvant or alternative to conventional modalities? Clin
    • [CrossRef][PubMed]
    • Bruland, O.S.; Nilsson, S.; Fisher, D.R.; Larsen, R.H. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223ra: Adjuvant or alternative to conventional modalities? Clin. Cancer Res. 2006, 12, 6250s–6257s. [CrossRef][PubMed]
    • (2006) Cancer Res , vol.12 , pp. 6250s-6257s
    • Bruland, O.S.1    Nilsson, S.2    Fisher, D.R.3    Larsen, R.H.4
  • 68
    • 84956571721 scopus 로고    scopus 로고
    • Impact of whole-body radiation dose on response and toxicity in patients with neuroblastoma after therapy with i-metaiodobenzylguanidine (Mibg)
    • CrossRef
    • Trieu, M.; DuBois, S.G.; Pon, E.; Nardo, L.; Hawkins, R.A.; Marachelian, A.; Twist, C.J.; Park, J.R.; Matthay, K.K. Impact of whole-body radiation dose on response and toxicity in patients with neuroblastoma after therapy with i-metaiodobenzylguanidine (mibg). Pediatr. Blood Cancer 2016, 63. [CrossRef]
    • (2016) Pediatr. Blood Cancer
    • Trieu, M.1    Dubois, S.G.2    Pon, E.3    Nardo, L.4    Hawkins, R.A.5    Marachelian, A.6    Twist, C.J.7    Park, J.R.8    Matthay, K.K.9
  • 70
    • 84924601329 scopus 로고    scopus 로고
    • Patient-specific dosimetry using pretherapy [124I]m-iodobenzylguanidine ([124I]mibg) dynamic pet/ct imaging before [131I]mibg targeted radionuclide therapy for neuroblastoma. Mol
    • [CrossRef][PubMed]
    • Huang, S.Y.; Bolch, W.E.; Lee, C.; van Brocklin, H.F.; Pampaloni, M.H.; Hawkins, R.A.; Sznewajs, A.; DuBois, S.G.; Matthay, K.K.; Seo, Y. Patient-specific dosimetry using pretherapy [124I]m-iodobenzylguanidine ([124I]mibg) dynamic pet/ct imaging before [131I]mibg targeted radionuclide therapy for neuroblastoma. Mol. Imaging Biol. 2015, 17, 284–294. [CrossRef][PubMed]
    • (2015) Imaging Biol , vol.17 , pp. 284-294
    • Huang, S.Y.1    Bolch, W.E.2    Lee, C.3    Van Brocklin, H.F.4    Pampaloni, M.H.5    Hawkins, R.A.6    Sznewajs, A.7    Dubois, S.G.8    Matthay, K.K.9    Seo, Y.10
  • 71
    • 0031814534 scopus 로고    scopus 로고
    • Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis
    • [CrossRef][PubMed]
    • Sgouros, G. Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis. Med. Phys. 1998, 25, 1487–1490. [CrossRef][PubMed]
    • (1998) Med. Phys. , vol.25 , pp. 1487-1490
    • Sgouros, G.1
  • 73
    • 84919774236 scopus 로고    scopus 로고
    • Therapeutic radionuclides in nuclear medicine: Current and future prospects
    • [CrossRef][PubMed]
    • Yeong, C.H.; Cheng, M.H.; Ng, K.H. Therapeutic radionuclides in nuclear medicine: Current and future prospects. J. Zhejiang Univ. Sci. B 2014, 15, 845–863. [CrossRef][PubMed]
    • (2014) J. Zhejiang Univ. Sci. B , vol.15 , pp. 845-863
    • Yeong, C.H.1    Cheng, M.H.2    Ng, K.H.3
  • 74
    • 84993740454 scopus 로고    scopus 로고
    • Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma
    • [CrossRef][PubMed]
    • Sanchez Ruiz, A.C.; de la Cruz-Merino, L.; Provencio Pulla, M. Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma. Ther. Adv. Hematol. 2014, 5, 78–90. [CrossRef][PubMed]
    • (2014) Ther. Adv. Hematol , vol.5 , pp. 78-90
    • Sanchez Ruiz, A.C.1    De La Cruz-Merino, L.2    Provencio Pulla, M.3
  • 75
    • 84880657268 scopus 로고    scopus 로고
    • 90yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-hodgkin lymphoma: Updated results after a median follow-up of 7. 3 years from the international, randomized, phase iii first-lineindolent trial
    • [CrossRef][PubMed]
    • Morschhauser, F.; Radford, J.; van Hoof, A.; Botto, B.; Rohatiner, A.Z.; Salles, G.; Soubeyran, P.; Tilly, H.; Bischof-Delaloye, A.; van Putten, W.L.; et al. 90yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-hodgkin lymphoma: Updated results after a median follow-up of 7. 3 years from the international, randomized, phase iii first-lineindolent trial. J. Clin. Oncol. 2013, 31, 1977–1983. [CrossRef][PubMed]
    • (2013) J. Clin. Oncol. , vol.31 , pp. 1977-1983
    • Morschhauser, F.1    Radford, J.2    Van Hoof, A.3    Botto, B.4    Rohatiner, A.Z.5    Salles, G.6    Soubeyran, P.7    Tilly, H.8    Bischof-Delaloye, A.9    Van Putten, W.L.10
  • 76
    • 55949118446 scopus 로고    scopus 로고
    • Phase iii trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma
    • [CrossRef][PubMed]
    • Morschhauser, F.; Radford, J.; van Hoof, A.; Vitolo, U.; Soubeyran, P.; Tilly, H.; Huijgens, P.C.; Kolstad, A.; d’Amore, F.; Gonzalez Diaz, M.; et al. Phase iii trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J. Clin. Oncol. 2008, 26, 5156–5164. [CrossRef][PubMed]
    • (2008) J. Clin. Oncol. , vol.26 , pp. 5156-5164
    • Morschhauser, F.1    Radford, J.2    Van Hoof, A.3    Vitolo, U.4    Soubeyran, P.5    Tilly, H.6    Huijgens, P.C.7    Kolstad, A.8    D’Amore, F.9    Gonzalez Diaz, M.10
  • 79
    • 84900322038 scopus 로고    scopus 로고
    • The role of pam4 in the management of pancreatic cancer: Diagnosis, radioimmunodetection, and radioimmunotherapy
    • [CrossRef][PubMed]
    • Han, S.; Jin, G.; Wang, L.; Li, M.; He, C.; Guo, X.; Zhu, Q. The role of pam4 in the management of pancreatic cancer: Diagnosis, radioimmunodetection, and radioimmunotherapy. J. Immunol. Res. 2014, 2014, 268479. [CrossRef][PubMed]
    • (2014) J. Immunol. Res , vol.2014
    • Han, S.1    Jin, G.2    Wang, L.3    Li, M.4    He, C.5    Guo, X.6    Zhu, Q.7
  • 80
    • 74849131675 scopus 로고    scopus 로고
    • Adioimmunotherapy of lymphoma: Bexxar and zevalin
    • R, [CrossRef][PubMed]
    • Goldsmith, S.J. Radioimmunotherapy of lymphoma: Bexxar and zevalin. Semin. Nucl. Med. 2010, 40, 122–135. [CrossRef][PubMed]
    • (2010) Semin. Nucl. Med , vol.40 , pp. 122-135
    • Goldsmith, S.J.1
  • 81
    • 84873397196 scopus 로고    scopus 로고
    • Phase iii randomized intergroup trial of chop plus rituximab compared with chop chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: Swog s0016
    • [CrossRef][PubMed]
    • Press, O.W.; Unger, J.M.; Rimsza, L.M.; Friedberg, J.W.; LeBlanc, M.; Czuczman, M.S.; Kaminski, M.; Braziel, R.M.; Spier, C.; Gopal, A.K.; et al. Phase iii randomized intergroup trial of chop plus rituximab compared with chop chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: Swog s0016. J. Clin. Oncol. 2013, 31, 314–320. [CrossRef][PubMed]
    • (2013) J. Clin. Oncol. , vol.31 , pp. 314-320
    • Press, O.W.1    Unger, J.M.2    Rimsza, L.M.3    Friedberg, J.W.4    Leblanc, M.5    Czuczman, M.S.6    Kaminski, M.7    Braziel, R.M.8    Spier, C.9    Gopal, A.K.10
  • 82
    • 84884202033 scopus 로고    scopus 로고
    • Phase iii randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (Beam) compared with iodine-131 tositumomab/beam with autologous hematopoietic cell transplantation for relapsed diffuse large b-cell lymphoma: Results from the bmt ctn 0401 trial
    • PubMed
    • Vose, J.M.; Carter, S.; Burns, L.J.; Ayala, E.; Press, O.W.; Moskowitz, C.H.; Stadtmauer, E.A.; Mineshi, S.; Ambinder, R.; Fenske, T.; et al. Phase iii randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (beam) compared with iodine-131 tositumomab/beam with autologous hematopoietic cell transplantation for relapsed diffuse large b-cell lymphoma: Results from the bmt ctn 0401 trial. J. Clin. Oncol. 2013, 31, 1662–1668. [PubMed]
    • (2013) J. Clin. Oncol. , vol.31 , pp. 1662-1668
    • Vose, J.M.1    Carter, S.2    Burns, L.J.3    Ayala, E.4    Press, O.W.5    Moskowitz, C.H.6    Stadtmauer, E.A.7    Mineshi, S.8    Ambinder, R.9    Fenske, T.10
  • 83
    • 84890284204 scopus 로고    scopus 로고
    • A comparative analysis of prognostic factor models for follicular lymphoma based on a phase iii trial of chop-rituximab versus chop + 131iodine—Tositumomab
    • [CrossRef][PubMed]
    • Press, O.W.; Unger, J.M.; Rimsza, L.M.; Friedberg, J.W.; LeBlanc, M.; Czuczman, M.S.; Kaminski, M.; Braziel, R.M.; Spier, C.; Gopal, A.K.; et al. A comparative analysis of prognostic factor models for follicular lymphoma based on a phase iii trial of chop-rituximab versus chop + 131iodine—Tositumomab. Clin. Cancer Res. 2013, 19, 6624–6632. [CrossRef][PubMed]
    • (2013) Clin. Cancer Res , vol.19 , pp. 6624-6632
    • Press, O.W.1    Unger, J.M.2    Rimsza, L.M.3    Friedberg, J.W.4    Leblanc, M.5    Czuczman, M.S.6    Kaminski, M.7    Braziel, R.M.8    Spier, C.9    Gopal, A.K.10
  • 84
    • 0041736032 scopus 로고    scopus 로고
    • Hla class ii antibodies in the treatment of hematologic malignancies
    • CrossRef
    • Dechant, M.; Bruenke, J.; Valerius, T. Hla class ii antibodies in the treatment of hematologic malignancies. Semin. Oncol. 2003, 30, 465–475. [CrossRef]
    • (2003) Semin. Oncol , vol.30 , pp. 465-475
    • Dechant, M.1    Bruenke, J.2    Valerius, T.3
  • 85
    • 84863637447 scopus 로고    scopus 로고
    • Targeted radioimmunotherapy: The role of 131I-chtnt-1/b mab (cotara) for treatment of high-grade gliomas
    • [CrossRef][PubMed]
    • Hdeib, A.; Sloan, A. Targeted radioimmunotherapy: The role of 131I-chtnt-1/b mab (cotara) for treatment of high-grade gliomas. Future Oncol. 2012, 8, 659–669. [CrossRef][PubMed]
    • (2012) Future Oncol , vol.8 , pp. 659-669
    • Hdeib, A.1    Sloan, A.2
  • 86
    • 84876097155 scopus 로고    scopus 로고
    • Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation
    • [CrossRef][PubMed]
    • Fujiki, M.; Aucejo, F.; Kim, R. Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: Do we really need this? Clin. Transplant. 2013, 27, 169–177. [CrossRef][PubMed]
    • (2013) Do We Really Need This? Clin. Transplant. , vol.27 , pp. 169-177
    • Fujiki, M.1    Aucejo, F.2    Kim, R.3
  • 89
    • 84925321749 scopus 로고    scopus 로고
    • Radium-223 in the treatment of osteoblastic metastases: A critical clinical review
    • [CrossRef][PubMed]
    • Humm, J.L.; Sartor, O.; Parker, C.; Bruland, O.S.; Macklis, R. Radium-223 in the treatment of osteoblastic metastases: A critical clinical review. Int. J. Radiat. Oncol. Biol. Phys. 2015, 91, 898–906. [CrossRef][PubMed]
    • (2015) Int. J. Radiat. Oncol. Biol. Phys , vol.91 , pp. 898-906
    • Humm, J.L.1    Sartor, O.2    Parker, C.3    Bruland, O.S.4    Macklis, R.5
  • 92
    • 84927153593 scopus 로고    scopus 로고
    • Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma
    • [CrossRef][PubMed]
    • Kayano, D.; Kinuya, S. Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: Reports so far and future perspective. Sci. World J. 2015, 2015, 1–9. [CrossRef][PubMed]
    • (2015) Reports So Far and Future Perspective. Sci. World J. , vol.2015 , pp. 1-9
    • Kayano, D.1    Kinuya, S.2
  • 93
    • 78650143642 scopus 로고    scopus 로고
    • Thyroid and hepatic function after high dose (131)i-metaiodobenzylguanidine ((131)i-mibg) therapy for neuroblastoma
    • [CrossRef][PubMed]
    • Quach, A.; Ji, L.; Mishra, V.; Sznewajs, A.; Veatch, J.; Huberty, J.; Franc, B.; Sposto, R.; Groshen, S.; Wei, D., et al. Thyroid and hepatic function after high dose (131)i-metaiodobenzylguanidine ((131)i-mibg) therapy for neuroblastoma. Pediatr. Blood Cancer 2011, 56, 191–201. [CrossRef][PubMed]
    • (2011) Pediatr. Blood Cancer , vol.56 , pp. 191-201
    • Quach, A.1    Ji, L.2    Mishra, V.3    Sznewajs, A.4    Veatch, J.5    Huberty, J.6    Franc, B.7    Sposto, R.8    Groshen, S.9    Wei, D.10
  • 94
    • 84941979029 scopus 로고    scopus 로고
    • Phase I study of vorinostat as a radiation sensitizer with 131i-metaiodobenzylguanidine (131i-mibg) for patients with relapsed or refractory neuroblastoma
    • [CrossRef][PubMed]
    • DuBois, S.G.; Groshen, S.; Park, J.R.; Haas-Kogan, D.A.; Yang, X.; Geier, E.; Chen, E.; Giacomini, K.; Weiss, B.; Cohn, S.L., et al. Phase I study of vorinostat as a radiation sensitizer with 131i-metaiodobenzylguanidine (131i-mibg) for patients with relapsed or refractory neuroblastoma. Clin. Cancer Res. 2015, 21, 2715–2721. [CrossRef][PubMed]
    • (2015) Clin. Cancer Res , vol.21 , pp. 2715-2721
    • Dubois, S.G.1    Groshen, S.2    Park, J.R.3    Haas-Kogan, D.A.4    Yang, X.5    Geier, E.6    Chen, E.7    Giacomini, K.8    Weiss, B.9    Cohn, S.L.10
  • 95
    • 84943661827 scopus 로고    scopus 로고
    • Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)i-metaiodobenzylguanidine ((131)i-mibg)
    • [CrossRef][PubMed]
    • Zhou, M.J.; Doral, M.Y.; DuBois, S.G.; Villablanca, J.G.; Yanik, G.A.; Matthay, K.K. Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)i-metaiodobenzylguanidine ((131)i-mibg). Eur. J. Cancer 2015, 51, 2465–2472. [CrossRef][PubMed]
    • (2015) Eur. J. Cancer , vol.51 , pp. 2465-2472
    • Zhou, M.J.1    Doral, M.Y.2    Dubois, S.G.3    Villablanca, J.G.4    Yanik, G.A.5    Matthay, K.K.6
  • 96
    • 84944447692 scopus 로고    scopus 로고
    • Radioprotective substances: History, trends and prospects
    • CrossRef
    • Gudkov, S.V.; Popova, N.R.; Bruskov V.I. Radioprotective substances: History, trends and prospects. Biophysics 2015, 60, 659–667. [CrossRef]
    • (2015) Biophysics , vol.60 , pp. 659-667
    • Gudkov, S.V.1    Popova, N.R.2    Bruskov, V.I.3
  • 97
    • 33646442741 scopus 로고    scopus 로고
    • Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice. Radiat
    • [CrossRef][PubMed]
    • Gudkov, S.V.; Shtarkman, I.N.; Smirnova, V.S.; Chernikov, A.V.; Bruskov V.I. Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice. Radiat. Res. 2006, 165, 538–545. [CrossRef][PubMed]
    • (2006) Res , vol.165 , pp. 538-545
    • Gudkov, S.V.1    Shtarkman, I.N.2    Smirnova, V.S.3    Chernikov, A.V.4    Bruskov, V.I.5
  • 98
    • 65649124554 scopus 로고    scopus 로고
    • Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine
    • [CrossRef][PubMed]
    • Gudkov, S.V.; Gudkova, O.Y.; Chernikov, A.V.; Bruskov V.I. Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine. Int. J. Radiat. Biol. 2009, 85, 116–125. [CrossRef][PubMed]
    • (2009) . Int. J. Radiat. Biol. , vol.85 , pp. 116-125
    • Gudkov, S.V.1    Gudkova, O.Y.2    Chernikov, A.V.3    Bruskov, V.I.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.